50 results
8-K
EX-2.1
ALIM
Alimera Sciences Inc.
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
to the non-performing Party’s respective employees or agents), fire, floods, pandemic, earthquakes or other acts of God, or any generally applicable
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
for 2021. The increase was predominantly due to our decision to invest in growth as we emerged from the pandemic to regain commercial momentum.
Cash
8-K
rwaflaa
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
r82y 854pwapac
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
c64m oxjen
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am
8-K
EX-99.1
twhs 610phob
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am
8-K
97rmxyas
7 Jun 22
Regulation FD Disclosure
8:56am
8-K
EX-99.1
mocnbj5
9 May 22
Alimera Sciences Reports First Quarter 2022 Results
8:40am
8-K
vsbqf r6mykb
9 May 22
Alimera Sciences Reports First Quarter 2022 Results
8:40am
8-K
4ddva
24 Feb 22
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
8:15am
8-K
EX-99.1
2rx1d0seitztggpy4
24 Feb 22
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
8:15am